A prospective, non-interventional study to evaluate the change in symptoms scores and treatment response after 4 weeks of systematic treatment with PPIs in GERD patients in primary care setting in Romania, using the validated GerdQ questionnaire.
Gastroesophageal reflux disease (GERD)
18 Years +
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
No locations available